1.
Hall, I.P., Pirmohamed, M.: Pharmacogenetics. Taylor & Francis, New York (2006).
2.
Gibb, Alasdair J., Foreman, John C., Johansen, Torben: Textbook of receptor pharmacology. CRC Press, Boca Raton, FL (2011). https://doi.org/10.1201/9781420052558.
3.
Kenakin, Terrence P.: A pharmacology primer: theory, applications, and methods. Elsevier Academic Press, Burlington, MA (2009).
4.
Burton, Paul, Palmer, Lyle, Smith, George Davey: An introduction to genetic epidemiology. Policy Press, Bristol (2011).
5.
Holmes, M.V., Shah, T., Vickery, C., Smeeth, L., Hingorani, A.D., Casas, J.P.: Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE. 4, (2009). https://doi.org/10.1371/journal.pone.0007960.
6.
Humphries, S.E., Hingorani, A.: Pharmacogenetics: Progress, pitfalls and clinical potential for coronary heart disease. Vascular Pharmacology. 44, 119–125 (2006). https://doi.org/10.1016/j.vph.2005.10.003.
7.
Neubig, R.R.: International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. Pharmacological Reviews. 55, 597–606 (2003). https://doi.org/10.1124/pr.55.4.4.
8.
Lefkowitz, R.J.: Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences. 25, 413–422 (2004). https://doi.org/10.1016/j.tips.2004.06.006.
9.
Seifert, R., Wenzel-Seifert, K.: Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg’s Archives of Pharmacology. 366, 381–416 (2002). https://doi.org/10.1007/s00210-002-0588-0.
10.
Thompson, A.J., Lester, H.A., Lummis, S.C.R.: The structural basis of function in Cys-loop receptors. Quarterly Reviews of Biophysics. 43, 449–499 (2010). https://doi.org/10.1017/S0033583510000168.
11.
Kirkwood, Betty R., Kirkwood, Betty R., Sterne, Jonathan A. C.: Essential medical statistics. Blackwell Science, Malden, Mass (2003).
12.
New Perspectives for the Elucidation of Genetic Disorders. https://doi.org/520679.
13.
Ropers, H.-H.: New Perspectives for the Elucidation of Genetic Disorders. The American Journal of Human Genetics. 81, 199–207 (2007). https://doi.org/10.1086/520679.
14.
Hirschhorn, J.N., Daly, M.J.: Genome-wide association studies for common diseases and complex traits. Nature Reviews Genetics. 6, 95–108 (2005). https://doi.org/10.1038/nrg1521.
15.
Botstein, D., Risch, N.: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genetics. 33, 228–237 (2003). https://doi.org/10.1038/ng1090.
16.
Capecchi, M.R.: Essay: Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nature Reviews Genetics. 6, 507–512 (2005). https://doi.org/10.1038/nrg1619.
17.
Brinkman, R.R., Dubé, M.-P., Rouleau, G.A., Orr, A.C., Samuels, M.E.: Human monogenic disorders — a source of novel drug targets. Nature Reviews Genetics. 7, 249–260 (2006). https://doi.org/10.1038/nrg1828.
18.
O’Connor, T.P., Crystal, R.G.: Genetic medicines: treatment strategies for hereditary disorders. Nature Reviews Genetics. 7, 261–276 (2006). https://doi.org/10.1038/nrg1829.
19.
Antonarakis, S.E., Beckmann, J.S.: Mendelian disorders deserve more attention. Nature Reviews Genetics. 7, 277–282 (2006). https://doi.org/10.1038/nrg1826.
20.
Table of contents : Nature Reviews Genetics Focus on Monogenic disorders.
21.
Hansson, G.K., Libby, P.: The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology. 6, 508–519 (2006). https://doi.org/10.1038/nri1882.
22.
Atherosclerosis — An Inflammatory Disease — NEJM.
23.
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 364, 937–952 (2004). https://doi.org/10.1016/S0140-6736(04)17018-9.
24.
Kathiresan, S., Voight, B.F., Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P.M., Anand, S., Engert, J.C., Samani, N.J., Schunkert, H., Erdmann, J., Reilly, M.P., Rader, D.J., Morgan, T., Spertus, J.A., Stoll, M., Girelli, D., McKeown, P.P., Patterson, C.C., Siscovick, D.S., O’Donnell, C.J., Elosua, R., Peltonen, L., Salomaa, V., Schwartz, S.M., Melander, O., Altshuler, D., Ardissino, D., Merlini, P.A., Berzuini, C., Bernardinelli, L., Peyvandi, F., Tubaro, M., Celli, P., Ferrario, M., Fetiveau, R., Marziliano, N., Casari, G., Galli, M., Ribichini, F., Rossi, M., Bernardi, F., Zonzin, P., Piazza, A., Mannucci, P.M., Schwartz, S.M., Siscovick, D.S., Yee, J., Friedlander, Y., Elosua, R.: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics. 41, 334–341 (2009). https://doi.org/10.1038/ng.327.
25.
Bras, J.M., Singleton, A.: Genetic susceptibility in Parkinson’s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792, 597–603 (2009). https://doi.org/10.1016/j.bbadis.2008.11.008.
26.
Altshuler, D., Daly, M.J., Lander, E.S.: Genetic Mapping in Human Disease. Science. 322, 881–888 (2008). https://doi.org/10.1126/science.1156409.
27.
McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P.A., Hirschhorn, J.N.: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics. 9, 356–369 (2008). https://doi.org/10.1038/nrg2344.
28.
Abou-Sleiman, P.M., Muqit, M.M.K., Wood, N.W.: Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nature Reviews Neuroscience. 7, 207–219 (2006). https://doi.org/10.1038/nrn1868.
29.
Sham, P.: Statistics in human genetics. Wiley, Chichester (2007).
30.
Thomas, Duncan C.: Statistical methods in genetic epidemiology. Oxford University Press, New York (2004).
31.
Balding, D.J.: A tutorial on statistical methods for population association studies. Nature Reviews Genetics. 7, 781–791 (2006). https://doi.org/10.1038/nrg1916.
32.
Neale, Benjamin M., International Workshop of Twin and Family Studies: Statistical genetics: gene mapping through linkage and association. Taylor & Francis, Abingdon (2008).
33.
Bishop, M., Cannings, C., Balding, D. J.: Handbook of statistical genetics. John Wiley, Chichester (2007).
34.
Foulkes, Andrea S.: Applied statistical genetics with R: for population-based association studies. Springer, Dordrecht (2009). https://doi.org/10.1007/978-0-387-89554-3.
35.
Daly, A.K.: Genome-wide association studies in pharmacogenomics. Nature Reviews Genetics. 11, 241–246 (2010). https://doi.org/10.1038/nrg2751.
36.
Holmes, M.V., Shah, T., Vickery, C., Smeeth, L., Hingorani, A.D., Casas, J.P.: Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE. 4, (2009). https://doi.org/10.1371/journal.pone.0007960.
37.
Lee, A.J.X., Swanton, C.: Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics. Biochemical Pharmacology. 83, 1013–1020 (2012). https://doi.org/10.1016/j.bcp.2011.12.008.
38.
Holmes, M.V.: CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association. 306, (2011). https://doi.org/10.1001/jama.2011.1880.
39.
Orengo, Christine Ann, Jones, David Tudor, Thornton, Janet M.: Bioinformatics: genes, proteins and computers. BIOS, Oxford (2003).
40.
Zvelebil, Marketa J., Baum, Jeremy O.: Understanding bioinformatics. Garland Science, New York (2008).
41.
Lesk, Arthur M.: Introduction to bioinformatics. Oxford University Press, Oxford (2008).